>>  Home  >>  Scientific Publications  >>  2005



Scientific Publications

Business Opportunities


Education & Training

Biological Safety

Unified Culture Collection

Special Pathogens Lab

Reference Materials

Related Links


Contact Us



— 2005 —

Aitichou M, Saleh SS, McElroy AK, Schmaljohn C, Ibrahim MS.  2005.  Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCR.  J Virol Meth 124:21-26.

Anderson AO, Shaw S.  2005.  Conduit for privileged communications in the lymph node.  Immunity 22:3-7.

Arndt JW, Gu J, Jaroszewski L, Schwarzenbacher R, Hanson MA, Lebeda FJ, Stevens RC.  2005.  The structure of the neurotoxin-associated protein HA33/A from Clostridium botulinum suggests a reoccurring beta-trefoil fold in the progenitor toxin complex.  J Mol Biol 346:1083-1093.

Blank TE, Carpenter BM, Chabot DJ, Peterson SN, Friedlander AM.  2005.  Deletions in the chromosome of the carbosap vaccine strain of Bacillus Anthracis.  Abstracts of the 105th General Meeting of the American Society for Microbiology,  p217.

Bozue JA, Parthasarathy N, Phillips LR, Cote CK, Fellows PF, Mendelson I, Shafferman A, Friedlander A.  2005.  Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs.  Microb Pathogen 38:1-12.

Bray M, Geisbert TW.  2005.  Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.  Int J Biochem Cell Biol 37:1560-1566.

Brittingham KC, Ruthel G, Panchal RG, Fuller CL, Ribot WJ, Hoover TA, Young HA, Anderson AO, Bavari S.  2005.  Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis.  J Immunol 174:5545-5552.

Burnett JC, Schmidt JJ, McGrath CF, Nguyen TL, Hermone AR, Panchal RG, Vennerstrom JL, Kodukula K, Zaharevitz DW, Gussio R, Bavari S.  2005.  Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor binding.  Bioorg Med Chem 13:333-341.

Christensen DR, Ulrich MP.  2005.  Comparison of the QIAGEN BioRobot EZ1 and the roche MagNA pure compact automated extraction instruments.  Abstracts of the 105th General Meeting of the American Society for Microbiology, p135.

Coyne SR, Shipley MA, Ulrich MP.  2005.  Evaluation of the imigene BPE reagent system for extracting PCR-amplifiable DNA from whole blood samples.  Abstracts of the 105th General Meeting of the American Society for Microbiology, p156.

Crosland RD, Fitch RW, Hines HB.  2005.  Characterization of �-leptinotarsin-h and the effects of calcium flux antagonists on its activity.  Toxicon 45:829-841.

Elson CO, Dertzbaugh MT.  2005.  Mucosal adjuvants, p 967-986. In J Mestecky, ME Lamm, W Strober, J Bienenstock, et al. (ed), Mucosal Immunology, 3rd edition, chapter 54, Academic Press, NY.

Gibson CM, Ulrich MP.  2005.  Comparison of sonication methods for cell disruption of Bacillus anthracis Sterne spores.  Abstracts of the 105th General Meeting of the American Society for Microbiology, p488.

Glynn A, Roy CJ, Powell BS, Adamovicz JJ, Freytag LC, Clements JD.  2005.  Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.  Infect Immun 73:5256-61.

Goodin JL, Raab RW, McKown RL, Coffman GL, Powell BS, Enama JT, Ligon JA, Andrews GP.  2005.  Yersinia pestis outer membrane type III secretion protein YscC: expression, purification, characterization, and induction of specific antiserum.  Protein Expr Purif 40:152-163.

Hartman LJ, Coyne SR, Norwood DA.  2005.  Development of a novel internal positive control for Taqman�-based assays.  Mol Cell Probes 19:51-59.

Hepburn M, Coyne SR, Norwood DA, Ulrich MP.  2005.  Rapid diagnostic techniques for detecting Francisella tularensis live vaccine strain from whole blood and swab samples.  Abstracts of the 105th General Meeting of the American Society for Microbiology, p136

Kallstrom, G, Warfield KL, Swenson DL, Mort S, Panchal RG, Ruthel G, Bavari S, Aman MJ.  2005.  Analysis of Ebola virus and VLP release using an immunocapture assay.  J Virol Methods 127:1-9.

Krakauer T, Chen X, Howard OMZ, Young HA.  2005.  Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines.  Immunopharmacol Immunotoxicol 27:53-56.

Lee MS, Salsbury Jr FR, Olson MA.  2005.  An efficient hybrid explicit/implicit solvent method for biomolecular simulations.  J Comput Chem 25:1967-1978.

Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S, Klaenhammer TR.  2005.  Lactobacilli activate human dendritic cells that skew T cells toward T helper1 polarization.  Proc Natl Acad Sci USA 102:2880-2885.

Panchal RG, Halverson K, Ribot W, Lane D, Kenny T, Abshire TG, Ezzell JW, Hoover TA.  2005.  Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.  J Biol Chem 280:10834-10839.

Paragas J, Blatt LM, Hartmann C, Huggins JW, Endy TP.  2005.  Interferon alfacon 1 is an inhibitor of SARS-corona virus in cell-based models.  Antivir Res 66:99-102.

Pittman PR, Leitman SF, Barrera Oro JG, Norris SL, Marano NM, Ranadive M, Sink BS, McKee Jr KT.  2005.  Protective antigen (PA) and toxin neutralization (TNA) antibody patterns in anthrax vaccinees undergoing plasmapheresis.  Clin Diag Lab Immunol 12:713-722.

Pittman PR, Norris SL, Coonan KM, McKee Jr KT.  2005.  An assessment of health status among medical research volunteers who served in Project Whitecoat program at Fort Detrick, Maryland.  Mil Med 170:183-187.

Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, Worsham P, Pullen JK, Ribot W, Hines H, Smith L, Heath DG, Adamovicz JJ.  2005.  Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.  Biotechnol Prog 21:1490-510.

Reed DS, Lind CM, Lackemeyer MG, Sullivan LJ, Pratt WD, Parker MD.  2005.  Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.  Vaccine 23:3139-3147.

Roy CJ, Warfield KL, Welcher BC, Gonzales RF, Larsen T, Hanson J, David CS, Krakauer T, Bavari S.  2005.  Human leukocyte antigen-DQ8 transgenic mice: a murine model to examine the toxicity of aerosolized staphylococcal enterotoxin B.  Infect Immun 73:2452-2460.

Ruthel G, Demmin GL, Kallstrom G, Javid MP, Badie SS, Will AB, Nelle T, Schokman R, Nguyen TL, Carra JH, Bavari S, Aman MJ.  2005.  Association of Ebola virus matrix protein VP40 with microtubules.  J Virol 79:4709-4719.

Schmidt JJ, Stafford RG.  2005.  Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.  Biochemistry 44:4067-4073.

Shipley MA, Coyne SR, Craw PD, Ulrich MP.  2005.  Evaluation of the DNA/RNA protect (TM) additive for nucleic acid preservation in diagnostic samples.  Abstracts of the 105TH General Meeting of the American Society for Microbiology, p135.

Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S.  2005.  Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.  Vaccine 23:3033-3042.

Swietnicki W, Powell BS, Goodin J. 2005. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.  Protein Expr Purif 42:166-72.

Turell MJ, Dohm DJ, Sardelis MR, O'Guinn ML, Andreadis TG, Blow JA.  2005.  An update on the potential of North American mosquitoes (Diptera: Culicidae) to transmit West Nile virus.  J Entomol 42:57-62.

Ulrich RL, Amemiya K, Waag DM, Roy CJ, DeShazer D.  2005.  Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice.  Vaccine 23:1986-1992.

Vogel P, Kell WM, Fritz DL, Parker MD, Schoepp RJ.  2005.  Early events in the pathogenesis of eastern equine encephalitis virus in mice.  Am J Pathol 37:159-171.